Nature Communications (Oct 2019)

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

  • Elena López-Isac,
  • Marialbert Acosta-Herrera,
  • Martin Kerick,
  • Shervin Assassi,
  • Ansuman T. Satpathy,
  • Jeffrey Granja,
  • Maxwell R. Mumbach,
  • Lorenzo Beretta,
  • Carmen P. Simeón,
  • Patricia Carreira,
  • Norberto Ortego-Centeno,
  • Ivan Castellvi,
  • Lara Bossini-Castillo,
  • F. David Carmona,
  • Gisela Orozco,
  • Nicolas Hunzelmann,
  • Jörg H. W. Distler,
  • Andre Franke,
  • Claudio Lunardi,
  • Gianluca Moroncini,
  • Armando Gabrielli,
  • Jeska de Vries-Bouwstra,
  • Cisca Wijmenga,
  • Bobby P. C. Koeleman,
  • Annika Nordin,
  • Leonid Padyukov,
  • Anna-Maria Hoffmann-Vold,
  • Benedicte Lie,
  • European Scleroderma Group†,
  • Susanna Proudman,
  • Wendy Stevens,
  • Mandana Nikpour,
  • Australian Scleroderma Interest Group (ASIG),
  • Timothy Vyse,
  • Ariane L. Herrick,
  • Jane Worthington,
  • Christopher P. Denton,
  • Yannick Allanore,
  • Matthew A. Brown,
  • Timothy R. D. J. Radstake,
  • Carmen Fonseca,
  • Howard Y. Chang,
  • Maureen D. Mayes,
  • Javier Martin

DOI
https://doi.org/10.1038/s41467-019-12760-y
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 14

Abstract

Read online

Systemic sclerosis (SSc) is a heterogeneous chronic autoimmune disease that affects the connective tissue. Here, López-Isac et al. identify 13 new risk loci for SSc as well as loci specific for limited cutaneous and diffuse SSc and, defining credible sets and performing functional annotation, highlight key pathways and cell types for SSc.